Clinical Trials Browser

Completed × Purpura, Thrombotic Thrombocytopenic × caplacizumab × Clear all

NCT02553317 2023-04-05

HERCULES

Phase 3 Completed

145 enrolled 20 charts 1 FDA

Purpura, Thrombotic Thrombocytopenic